总裁 CEO
Troy Edward Wilson, Ph.D., J.D., is a director of Puma Biotechnology, Inc. (PBYI) and a seasoned biotechnology entrepreneur and executive.[[8]](https://investor.pumabiotechnology.com/static-files/19404fcb-b952-4712-93dc-2a633485c19e)[[9]](https://www.pumabiotechnology.com/about/bod.html) He has served on Puma’s board of directors since October 2013, including membership on the Audit Committee, and is identified in SEC filings as “WILSON TROY EDWARD” in his capacity as a company director (Dir.) and reporting insider.[[1]](https://www.pumabiotechnology.com/about/twilson.html)[[8]](https://investor.pumabiotechnology.com/static-files/19404fcb-b952-4712-93dc-2a633485c19e)[[9]](https://www.pumabiotechnology.com/about/bod.html) In addition to his role at Puma, he is President, Chief Executive Officer, and Chairman of the Board of Kura Oncology, Inc., a clinical‑stage biopharmaceutical company he co‑founded in 2014 to develop precision oncology therapeutics.[[1]](https://www.pumabiotechnology.com/about/twilson.html)[[2]](https://kuraoncology.com/leadership/troy-wilson/)[[4]](https://www.biotech2050.com/episodes/the-promise-of-precision-oncology-troy-wilson-president-amp-ceo-kura-oncology)
Wilson is widely recognized as a serial biotech founder, having co‑founded and led multiple drug development companies including Intellikine, Wellspring Biosciences, Araxes Pharma, Avidity Biosciences, Ambrx, and others, several of which were acquired by large pharmaceutical firms such as Takeda and Novartis.[[1]](https://www.pumabiotechnology.com/about/twilson.html)[[2]](https://kuraoncology.com/leadership/troy-wilson/)[[3]](https://www.marketscreener.com/insider/TROY-WILSON-A1J9GR/)[[4]](https://www.biotech2050.com/episodes/the-promise-of-precision-oncology-troy-wilson-president-amp-ceo-kura-oncology)[[5]](https://cartography.bio/teams/troy-wilson/) He currently serves on the boards of Atrium Therapeutics, Cartography Biosciences, Montara Therapeutics, Cipher Genetics, and Puma Biotechnology, among others.[[2]](https://kuraoncology.com/leadership/troy-wilson/)[[5]](https://cartography.bio/teams/troy-wilson/) Wilson holds a J.D. from New York University and earned both a Ph.D. in bioorganic chemistry and a B.A. in biophysics from the University of California, Berkeley.[[1]](https://www.pumabiotechnology.com/about/twilson.html)[[2]](https://kuraoncology.com/leadership/troy-wilson/)[[4]](https://www.biotech2050.com/episodes/the-promise-of-precision-oncology-troy-wilson-president-amp-ceo-kura-oncology)[[5]](https://cartography.bio/teams/troy-wilson/)
查看完整内部人档案 →